N. Xenidis

1.1k total citations
15 papers, 912 citations indexed

About

N. Xenidis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, N. Xenidis has authored 15 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in N. Xenidis's work include Cancer Cells and Metastasis (9 papers), Metastasis and carcinoma case studies (5 papers) and Cancer and Skin Lesions (4 papers). N. Xenidis is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Metastasis and carcinoma case studies (5 papers) and Cancer and Skin Lesions (4 papers). N. Xenidis collaborates with scholars based in Greece and Belgium. N. Xenidis's co-authors include Maria Perraki, Stella Apostolaki, Aliki Stathopoulou, Vassilis Georgoulias, Maria Kafousi, Evi Lianidou, D. Mavroudis, Dimitris Mavroudis, Ch. Kouroussis and N. Malamos and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

N. Xenidis

15 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Xenidis Greece	8	778	620	281	177	85	15	912
Steve Gross United States	8	541 0.7×	348 0.6×	255 0.9×	171 1.0×	138 1.6×	14	733
Marianne Oulhen France	13	560 0.7×	501 0.8×	365 1.3×	205 1.2×	84 1.0×	20	756
Carolina Reduzzi Italy	14	434 0.6×	366 0.6×	165 0.6×	200 1.1×	81 1.0×	56	630
Wendy Onstenk Netherlands	19	455 0.6×	456 0.7×	397 1.4×	257 1.5×	65 0.8×	25	813
Natalia Krawczyk Germany	18	578 0.7×	396 0.6×	172 0.6×	142 0.8×	56 0.7×	44	689
Giulia Gallerani Italy	12	421 0.5×	331 0.5×	123 0.4×	241 1.4×	119 1.4×	27	663
Francesca De Luca Italy	11	446 0.6×	371 0.6×	259 0.9×	193 1.1×	48 0.6×	18	610
Emma Pailler France	12	570 0.7×	534 0.9×	407 1.4×	149 0.8×	61 0.7×	18	723
Fanny Billiot France	10	554 0.7×	435 0.7×	280 1.0×	193 1.1×	153 1.8×	11	735
Marco Torregroza Otero Spain	6	651 0.8×	233 0.4×	258 0.9×	104 0.6×	35 0.4×	7	800

Countries citing papers authored by N. Xenidis

Since Specialization

Citations

This map shows the geographic impact of N. Xenidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Xenidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Xenidis more than expected).

Fields of papers citing papers by N. Xenidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Xenidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Xenidis. The network helps show where N. Xenidis may publish in the future.

Co-authorship network of co-authors of N. Xenidis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Xenidis. A scholar is included among the top collaborators of N. Xenidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Xenidis. N. Xenidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Balgkouranidou, Ioanna, N. Xenidis, Kyriakos Amarantidis, et al.. (2019). Methylation status of RASSF1A associates with prognosis in metastatic gastric cancer. Gastroenterology & Hepatology Open Access. 10(6). 301–304. 1 indexed citations

Xenidis, N., Maria Perraki, Stella Apostolaki, et al.. (2013). Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer. British Journal of Cancer. 108(3). 549–556. 25 indexed citations

Xenidis, N., Maria Perraki, Stella Apostolaki, et al.. (2011). Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumor cells in patients with early breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 10554–10554. 4 indexed citations

Mavroudis, D., Ioannis Boukovinas, N. Xenidis, et al.. (2010). A phase I/II study of docetaxel/epirubicin/bevacizumab (DEB) as first-line therapy for metastatic, HER2-negative breast cancer (MBC).. Journal of Clinical Oncology. 28(15_suppl). 1116–1116. 1 indexed citations

Agelaki, Sofia, Maria Perraki, Stella Apostolaki, et al.. (2009). Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. British Journal of Cancer. 101(4). 589–597. 79 indexed citations

Xenidis, N., Stella Apostolaki, Maria Perraki, et al.. (2007). Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer. Annals of Oncology. 18(10). 1623–1631. 56 indexed citations

Ignatiadis, Michail, Maria Perraki, Stella Apostolaki, et al.. (2007). Molecular Detection and Prognostic Value of Circulating Cytokeratin-19 Messenger RNA–Positive and HER2 Messenger RNA–Positive Cells in the Peripheral Blood of Women with Early-Stage Breast Cancer. Clinical Breast Cancer. 7(11). 883–889. 42 indexed citations

Xenidis, N., Stella Apostolaki, Maria Perraki, et al.. (2007). Clinical relevance of circulating CK-19 mRNA-positive cells detected during the period of adjuvant tamoxifen treatment in patients with early breast cancer. Journal of Clinical Oncology. 25(18_suppl). 10534–10534. 1 indexed citations

Ignatiadis, Michail, N. Xenidis, Maria Perraki, et al.. (2007). Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer. Journal of Clinical Oncology. 25(33). 5194–5202. 191 indexed citations

10.

Apostolaki, Stella, Maria Perraki, Eleni Politaki, et al.. (2006). Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer.. Cancer Research. 66. 1207–1207. 3 indexed citations

11.

Boukovinas, Ioannis, N. Androulakis, L. Vamvakas, et al.. (2006). Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group. Annals of Oncology. 17(11). 1687–1692. 11 indexed citations

12.

Xenidis, N., Maria Perraki, Maria Kafousi, et al.. (2006). Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients. Journal of Clinical Oncology. 24(23). 3756–3762. 214 indexed citations

13.

Xenidis, N., Dimitriοs Mavroudis, Stella Apostolaki, et al.. (2006). Effect of adjuvant treatment on the circulating CK-19 mRNA-positive tumor cells in patients with early stage breast cancer. Journal of Clinical Oncology. 24(18_suppl). 20012–20012. 4 indexed citations

14.

Xenidis, N., Charalambos Kouroussis, Athanasios Pallis, et al.. (2005). Effect of adjuvant tamoxifen and letrozol on the fate of peripheral blood CK-19 mRNA+ cells in patients with early breast cancer. Journal of Clinical Oncology. 23(16_suppl). 754–754. 3 indexed citations

15.

Stathopoulou, Aliki, Ioannis G. Vlachonikolis, D. Mavroudis, et al.. (2002). Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance. Journal of Clinical Oncology. 20(16). 3404–3412. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact